ACM Biosciences AG was established in Basel, Switzerland in September 2020. It is dedicated to the development of infectious disease vaccines using it's proprietary ACM polymersome platform technology. Its current primary focus is to get a safe, effective and highly manufacturable COVID-19 vaccine through clinical trials.
Company Details
- Employees
- 2
- Founded
- 2020
- Address
- Steinenberg 1, Basel,4051,switzerland
- Industry
- Biotechnology
- Website
- http://www.acmbiosciences.com
- Keywords
- Human vaccines platform, Polymersome platform, Nanocarrier platform, SARS-CoV-2 variants, B.1.351 variant.
- HQ
- Basel
Acm Biosciences Ag Questions
Acm Biosciences Ag's website is http://www.acmbiosciences.com
Acm Biosciences Ag's LinkedIn profile is https://ch.linkedin.com/company/acm-biosciences-ag
Acm Biosciences Ag has
2 employees.
View email and phone details for 2
employees at Acm Biosciences Ag.
Acm Biosciences Ag's industry is
Biotechnology
Acm Biosciences Ag's top competitors are
Myria Biosciences Ag,
Lyo-X Ag,
Salmon Pharma,
Nextwavebio,
Alentis Therapeutics,
I-Dna Biotechnology Pte Ltd,
Biosyngen,
Inozyme Pharma,
Spherobiotics,
Acm Biolabs.
Acm Biosciences Ag's categories are Biotechnology
Acm Biosciences Ag's founding year is 2020
